Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal Hernia: a Multicenter, Randomized, Parallel-group, Evaluator Blinded, Phase III Clinical Trial

NCT05867225 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05867225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal Hernia: a Multicenter, Randomized, Parallel-group, Evaluator Blinded, Phase III Clinical Trial
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Recruiting
Start date
January 15, 2024
Completion date
January 18, 2028
Enrollment
256 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

large hiatal hernia